November 6, 2025 · Form 4 insider transaction
Edwards Larry Todd sold 29,131 shares of Arcutis Biotherapeutics, Inc. at $25.16 per share, a transaction worth $732.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.2600, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.